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The Arabidopsis ABC transporter 
COMATOSE (CTS; AtABCD1) is required 
for uptake into the peroxisome of a wide 
range of substrates for β-oxidation, but it is 
uncertain whether CTS itself is the 
transporter or if the transported substrates 
are free acids or CoA esters. To establish a 
system for its biochemical analysis, CTS 
was expressed in Saccharomyces cerevisiae. 
The plant protein was correctly targeted to 
yeast peroxisomes, was assembled into the 
membrane with its nucleotide binding 
domains in the cytosol and exhibited basal 
ATPase activity that was sensitive to 
aluminium fluoride and abrogated by 
mutation of a conserved Walker A motif 
lysine residue. The yeast pxa1 pxa2Δ 
mutant lacks the homologous peroxisomal 
ABC transporter and is unable to grow on 
oleic acid. Consistent with its exhibiting a 
function in yeast akin to that in the plant, 
CTS rescued the oleate growth phenotype 
of the pxa1 pxa2Δ mutant, and restored β-
oxidation of fatty acids with a range of 
chain lengths and varying degrees of 
desaturation. When expressed in yeast 
peroxisomal membranes, the basal ATPase 
activity of CTS could be stimulated by fatty 
acyl CoAs but not by fatty acids. The 
implications of these findings for the 
function and substrate specificity of CTS 
are discussed. 
Peroxisomes perform a range of 
different functions, including β-oxidation of 
fatty acids (FA) and synthesis and degradation 
of bioactive, lipid-derived molecules. Import 
of substrates for peroxisomal metabolism is 
mediated by ATP Binding Cassette (ABC) 
transporters belonging to subclass D (1,2). 
ABC transporters are composed of a minimum 
of four functional domains: two 
transmembrane domains (TMDs), involved in 
substrate binding and translocation and two 
nucleotide binding domains (NBDs) which 
bind and hydrolyse ATP, providing energy for 
transport (3,4). The domains may be fused into 
a single polypeptide, but are frequently 
expressed as half-size transporters composed 
of a TMD fused to an NBD, which hetero- or 
homodimerise to form a functional transporter. 
Baker’s yeast (Saccharomyces cerevisiae) 
contains two ABCD genes which encode half-
size ABC proteins: Pxa1p (Peroxisomal ABC-
transporter 1), and Pxa2p (5-7). The single 
pxa1Δ and pxa2Δ deletion mutants are unable 
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to grow on oleate (C18:1) as the sole carbon 
source and exhibit reduced β-oxidation of this 
long chain FA. It has been proposed that 
Pxa1p and Pxa2p operate as a heterodimer to 
form a functional transporter (6,8,9) which has 
been shown by indirect evidence to be 
required for the peroxisomal transport of the 
C18:1-CoA, a long-chain acyl CoA ester, but 
not for import of C8:0-CoA (10). In contrast, 
medium-chain FAs enter yeast peroxisomes as 
free acids independently of Pxa1p/Pxa2p, and 
are activated by peroxisomal acyl CoA 
synthetase, Faa2p, prior to β-oxidation (6). 
The human ABCD transporter 
subfamily comprises four half-size members: 
Adrenoleukodystrophy protein (ALDP), ALD-
related protein (ALDRP), the 70 kDa 
peroxisomal membrane protein (PMP70) and 
PMP70-related protein (PMP70R/PMP69) 
(1,2). Although ALDP, ALDRP and PMP70 
have been implicated in lipid transport across 
the peroxisomal membrane (2,11-13), the 
precise biochemical functions of these 
transporters are not well understood. However, 
ALDP partially complements the yeast pxa1 
pxa2Δ mutant for growth on oleate and β-
oxidation of long chain FAs (9), suggesting 
that ALDP acts as a homodimeric transporter 
that accepts acyl-CoA esters (9). In addition, 
in a study using protease-sensitivity as a probe 
of conformational changes in ALDP, increased 
sensitivity was observed upon addition of long 
and very long chain FA-CoAs but not free FAs 
(14). Taken together, these studies suggest a 
role of ALDP in the transport of very long 
chain FA-CoAs across the peroxisome 
membrane, although this hypothesis awaits 
confirmation by carrying out transport studies 
in a reconstituted system. 
The reference plant Arabidopsis 
thaliana contains a single peroxisomal ABC 
transporter that has been identified in at least 
four independent forward genetic screens and 
is known as AtABCD1 (15), CTS 
(COMATOSE;16), AtPXA1 (Arabidopsis 
thaliana peroxisomal ABC transporter 1;17), 
PED3 (Peroxisomal defective 3;18) and ACN2 
(Acetate non-utilising 2; 19), referred to 
hereafter as CTS. Unlike the yeast and 
mammalian peroxisomal ABC proteins, CTS 
encodes a full-size ABC protein with two 
dissimilar halves. Analysis of cts null mutants 
has demonstrated that CTS plays key roles in a 
number of developmental and physiological 
processes, including germination, seedling 
establishment, fertility, root growth and dark-
induced senescence (16-18; 20-27). The 
different roles of CTS in planta are separable 
by mutagenesis (28) and can be related to 
different biochemical roles, specifically the 
ability to metabolise distinct substrates such as 
fatty acids and hormone precursors via β-
oxidation. Taken together, these findings 
strongly suggest that CTS is a transporter with 
broad acyl chain specificity which mediates 
uptake of substrates for β-oxidation into the 
peroxisome. However this conclusion is based 
on inferences from amino acid sequence 
identity with better characterised ABC 
transporters and in vivo mutant phenotypes 
which can be pleiotropic. There has been no 
direct biochemical evidence to support this 
interpretation. Additionally, there are 
arguments in favour of both acyl CoAs (16) 
and free fatty acids as substrates (29). 
Because plant peroxisomes are fragile 
and difficult to purify from Arabidopsis 
seedlings free from mitochondrial 
contamination, in this paper, we have carried 
out biochemical characterisation of 
heterologously-expressed CTS, and provide 
evidence for its role as a transporter of fatty 
acyl-CoAs. 
 
Experimental Procedures 
 
Yeast strains and culture conditions- The yeast 
strains used in this study are shown in Table 1. 
Yeast transformants were selected and grown 
on minimal medium with appropriate 
supplements. A single colony of yeast was 
inoculated into 10 ml of WOYD medium 
[0.67% (w/v) yeast nitrogen base (BD 
Biosciences, Oxford, UK), 0.3% (w/v) 
glucose, 0.1% (w/v) yeast extract] and 
incubated at 28° C for 18 h.  For peroxisome 
proliferation, 5 ml of the resultant yeast 
suspension was used to inoculate a litre of 
oleate medium [0.5% (w/v) bacto peptone, 
0.3% (w/v) yeast extract, 0.12% (v/v) oleic 
acid 0.2% (v/v) Tween 20, 0.5% (w/v) 
KH2PO4, pH 6.0] followed by incubation at 
28° C for 18 h (OD600 of 1.0 to 1.5) (30). 
Construction of a pxa1Δ mutant strain Gene 
replacement was used to generate a BSL1-11 
B strain lacking the PXA1 gene. The KanMX4 
disruption cassette was amplified using 
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primers PXA1KOF 
(CGTTTCAGACAATCTGGAAGTCTTAGA
ACGCATAACACAGAAATGGCTTCGTAC
GCTGCAGGTCG) and PXA1KOR 
(ATTATATTCGCTAAATAAAATCTCTCC
CTTTCTAGGGTGTTTTCACACTATAGGG
AGACCGGCAGATCC) with plasmid 
pFA6kanMX4 (31) as template. The following 
programme was used: 95° C, 2 min; 30 cycles 
of (94° C, 30 sec; 60° C, 30 sec; 72° C, 1 min), 
followed by a final extension at 72° C for 5 
min. The PCR product was transformed into 
BSL1-11B cells and putative pxa1Δ knockouts 
were selected on SD agar supplemented with 
500 μg/ml geneticin (G418; Melford, Ispwich, 
Suffolk, UK). Following re-streaking on SD 
agar plates containing geneticin, colonies were 
inoculated in WOYD medium for genomic 
DNA extraction (32). Integration of the 
cassette in the correct locus was confirmed by 
PCR.  
Construction of CTS expression plasmids- To 
generate a construct for expression of CTS in 
S.cerevisiae, a Vsp I (blunt)/ Eco RI fragment 
containing the CTS ORF was ligated into the 
Sma I/   Eco RI sites of pRS416-GPD (33,34), 
to give CTS/pRS416-GPD. The K487A 
mutant was generated by site-directed 
mutagenesis, as described in Dietrich et al., 
2009 (28). In order to create an in-frame CFP 
fusion with a ten amino acid spacer between 
the C-terminus of CTS and CFP, the native 
stop codon of CTS was removed by site-
directed mutagenesis using the QuikchangeII 
site directed mutagenesis kit (Stratagene, La 
Jolla, CA), with primer pair CTSstopF 
(GAACAGACAACAGAGTCAGAATTCGA
TATCAAGC) and CTSstopR 
(CTTGTCTGTTGTCTCAGTCTTAAGCTAT
AGTTCG), according to manufacturer’s 
instructions. The removal of the stop codon 
and absence of second site mutations were 
confirmed by sequencing of the entire CTS 
coding sequence. CFP was then amplified 
using primers CFPsF 
(AATTGGGGAATTCGGTTCAGCAGCTGG
ATCAGGTGCTAGCGCAATGGTGAGCAA
GGGCGAGG) and CFPR 
(CCCAATTGAATTCTTACTTGTACAGCA
CGTCCATGCC), with plasmid pVKh18En6 
CFP-SKL (35) as template. The following 
PCR programme was used: 94° C, 2 min; 94° 
C, 30 sec, 65° C, 30 sec, 72° C, 1 min (30 
cycles) plus a final extension for 5 min at 72° 
C. The primers introduced Eco RI restriction 
sites for subsequent cloning into CTS 
/pRS416GPDlinearised with Eco RI. The 
orientation of CFP was confirmed by 
sequencing. To generate a construct for 
complementation studies, a Bam HI/Sal I 
fragment containing the CTS ORF was 
excised from the CTS/pRS416-GPD  plasmid 
and ligated into the Bam HI/Sal I sites of 
pEL30 (36), to give CTS/pEL30. The 
construction of ALDP/pEL30 is described in 
(9). 
Subcellular fractionation- A light 
mitochondrial fraction was prepared 
essentially according to (30). Briefly, yeast 
cells grown overnight on oleate medium were 
converted to spheroplasts with Zymolase 20T 
(ICN Biomedicals, Illkirch, France) at a 
concentration of 1 mg/g cells. Spheroplasts 
were washed twice in wash buffer (50 mM 
potassium phosphate pH 7.5, 1 mM EDTA, 1 
mM KCl, 1.2 M sorbitol) before osmotic lysis 
in breaking buffer (5 mM MES pH 5.5, 1 mM 
EDTA, 1 mM KCl, 0.65 M sorbitol) followed 
by Dounce homogenisation. This and all 
subsequent steps were carried out at 4o C. 
Unbroken cells and nuclei were removed by 
centrifuging the homogenate twice at 2000 g 
for 10 min. The post-nuclear supernatants 
were further centrifuged at 20 000 g for 30 
min to obtain a light mitochondrial fraction 
(pellet), containing mitochondria and 
peroxisomes. Organelles were purified further 
by centrifugation through an iodixanol density 
gradient. The organelle pellet was resuspended 
in 5 ml homogenisation buffer using 2 gentle 
strokes with a loose-fitting (Wheaton type B) 
Dounce homogeniser pestle and an equal 
volume of 47 % (w/v) Optiprep (Axis Shield 
POC Oslo, Norway) was added. The mixture 
was carefully overlaid on a 2 ml cushion of 35 
% (w/v) Optiprep and centrifuged at 110 000 g 
for 2 h in a swing-out rotor. Homogenisation 
buffer and gradient medium contained 
protease inhibitors: 1 mM PMSF (Sigma, 
Poole, Dorset, UK), 1 µg/ml Pefabloc® SC 
(Sigma) and 1:50 dilution of complete 
protease inhibitor cocktail tablets (Roche, 
Welwyn, UK).  
Immunoblotting- was carried out as described 
in (16). Dilutions of primary antibodies were 
as follows: affinity-purified anti-CTS, 1:1,000 
(16); anti-thiolase, 1:100 (37); anti-AAC, 
1:2,000 (38); anti SRP72 1:4,000, (39).  
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Carbonate and salt extractions- A light 
mitochondrial fraction was prepared as above. 
The pellet was resuspended in 10X volume of 
hypotonic lysis buffer at 4 ºC [10 mM Tris–
HCl pH 8.5, containing 1 mM PMSF, 1 µg/ml 
Pefabloc® SC (Sigma) and 1:50 dilution of 
complete protease inhibitor cocktail tablets 
(Roche)]. The pellet was disrupted in a 
Dounce homogeniser with a tight fitting pestle, 
using 10 stokes at 4 ºC. The mixture was 
incubated at 4 ºC for 20 min followed by 
homogenisation as above. The mixture was 
centrifuged at 100 000 g for 1 hr at 4 ºC to 
pellet membranes and the supernatant was 
collected as the soluble fraction. The pellet 
(membrane fraction) was resuspended either in 
salt extraction buffer (1 M NaCl, 10 mM Tris-
HCl, pH 8.5, or 100 mM Na2CO3, pH 11.5, 
supplemented with 10 mM DTT), to a 
concentration of 500 μg/ml; each solution 
contained protease inhibitors. The mixture was 
homogenised and incubated at 4 ºC for 30 min 
followed by repeat homogenisation and 
centrifugation to pellet membrane proteins. 
The pellet and supernatant fractions were 
assayed by SDS-PAGE and immunoblotting. 
Determination of the orientation of nucleotide 
binding domains (NBDs).- A light 
mitochondrial fraction was homogenised in 
trypsin digestion buffer (0.65 M sorbitol, 50 
mM Tris-HCl buffer, pH 7.5). For protease 
protection experiments, reactions contained 
100 µl homogenate (1 mg/ml protein) and 0-
50 µg trypsin (Sigma), in the presence or 
absence of 0.1% (v/v) Triton X-100. Reactions 
were incubated on ice for 30 min and the 
reaction was stopped by the addition of 200 µl 
of 10 mg/ml Soybean trypsin inhibitor (SBTI; 
Sigma). The samples were homogenised in 
10X volume of 0.1 M Na2CO3 pH 11.5, 
supplemented with 10 mM DTT and carbonate 
extraction carried out as above. The pellets 
and supernatants were analysed by 
immunoblotting with anti-CTS and anti-
thiolase antibodies.  
Confocal microscopy of yeast cells- Yeast 
transformed with plasmids to co-express CTS-
CFP (CTS-CFP/pRS416GPD) and YFP-PTS1 
(pEW205) was grown in 10 ml of WOYD 
medium at 28 oC for 18 h. Cells were 
harvested by centrifugation at 5000 g, and 
resuspended in 1 ml water. The suspension 
was used to inoculate oleate medium at an 
OD600 of 0.15. Following growth at 28 oC for 
12 h, cells were harvested by centrifugation at 
5 000 g for 5 min, washed in deionised water 
and resuspended in WOYD medium 
supplemented with Mitotracker Orange® 
(Invitrogen) at a final concentration of 12.5 
nM. The cells were incubated at 30 oC for 30 
min, harvested and washed twice in WOYD 
medium pre-warmed to 37 °C. The cells were 
mounted in solution containing 90 % (v/v) 
glycerol and 100 mM Tris-HCl pH 8.5 and 
visualised by confocal laser scanning 
microscopy. An inverted laser scanning 
microscope (LSM 510; Zeiss, Jena, Germany) 
with argon, HeNe1, diode lasers and a 63x oil 
immersion objective was used for confocal 
imaging. The pinhole was set to give confocal 
sections of 1.2 μm. CFP was excited with a 
405 nm laser and fluorescence collected 
through a band pass of 475-525 nm, YFP was 
excited at 514 nm and fluorescence collected 
through a band pass of 530- 600 nm and 
Mitotracker® was excited with a 543 nm laser 
and fluorescence collected through a  band 
pass filter of 560-615 nm.  All images were 
scanned using identical conditions (laser 
power, gain of photomultiplier tube, pinhole 
size, and zoom). Post-acquisition image 
processing was done using the LSM 5 browser 
(Zeiss) and Adobe Photoshop 9.0 software 
(Adobe Systems, Mountain View, CA, USA).  
ATPase assays- The basal Mg2+-dependent 
ATPase activity of peroxisomes isolated from 
control yeast and yeast expressing CTS was 
determined by measuring the release of 
inorganic phosphate from ATP using a 
colorimetric method (40). The assay was 
optimised to be linear with respect to time and 
enzyme concentration (peroxisome protein) 
(Fig S2). Reactions contained 40 mM Tris-
HCl, pH 7.4, 0.1 mM EGTA, 1 mM DTT, 15 
mM MgSO4, 10 mM sodium azide, 2 mM 
ouabain, 55 μM molybdate and 10 μg of 
peroxisome proteins in a volume of 95 µl. 
Following equilibration at 37 ºC for 10 min, 
the reaction was started by the addition of 5 μl 
Mg-ATP solution (7 mM MgSO4, 5 mM ATP) 
and incubated at 37 ºC for 20 min. Reactions 
were stopped by the addition of 100 µl 12% 
(w/v) SDS, before colour development as 
described (40). Where indicated, inhibitors [10 
mM AlFx, (added by mixing an equimolar 
concentration of aluminium chloride and 
sodium fluoride); 100 µM sodium 
orthovanadate or 10 μM Concamycin A] were 
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added to the reaction mix before allowing the 
reactants to equilibrate. ATPase activity was 
also assayed in the presence of fatty acids (Nu-
Chek Prep, Inc., Elysian, MN) or fatty acyl-
CoAs (Avanti Polar Lipids Inc, Alabaster, 
Alabama) in the range of 0 to 1000 µM (final 
concentration). In these assays, MgSO4 was 
reduced to 2.5 mM, to avoid precipitation of 
acyl-CoAs (41,42). Substrates were solubilised 
in 5 % (w/v) 2-hydroxypropylated β-
cyclodextrin  (HPBCD) (43) and incubated in 
the ATPase reaction mix at 37 ºC for 10 min to 
equilibrate the reactants and to allow substrate 
recognition and binding before starting the 
reaction with MgATP as above. Data were 
analysed by one-way or two-way analysis of 
variance (ANOVA) and expressed as means 
(nmol Pi/mg/min) ± 95% confidence limit 
(CL). The stimulation indices (SI) for different 
compounds were calculated as [CTS 
expressing (stimulated) - control (stimulated)] 
/ [CTS (unstimulated) - control 
(unstimulated)]. Data were expressed as mean 
SI ± 95% CL, where 95% CL was determined 
according to the formula: 95% CL = mean ± (t 
x SEM), where n=number of samples, t = 
value of the Student t-distribution at (n-1) 
degrees of freedom and SEM is the standard 
error of the mean. All the statistical analysis 
and calculations were done using Origin® 8.0 
Data Analysis and Graphing Software 
statistical package and Windows® Microsoft 
Excel. 
Complementation of pxa1 pxa2Δ- Transformed 
yeast cells were grown in minimal medium 
containing 0.67 % (w/v) yeast nitrogen base 
without amino acids, supplemented with 0.3% 
(w/v) glucose and amino acids (20 mg/l), if 
required, at 28 °C for 24 h. For the induction 
of peroxisome proliferation, cells were shifted 
to YPO medium containing 0.5 % potassium 
phosphate buffer, pH 6.0, 0.3 % (w/v) yeast 
extract, 0.5 % (w/v) peptone supplemented 
with 0.12 % (w/v) oleate and 0.2 % (w/v) 
Tween-80. Cultures were incubated for 150 h 
in an orbital shaker at 200 rpm. The OD600 was 
measured every 12 h by mixing 100 μl of 
culture, 50 μl of 10% (v/v) Triton X-100, and 
850 μl water. Oleic acid plates contained 0.125 
% (w/v) oleic acid, 0.4 % (w/v) Tween-80, 2 
% (w/v) agar, 0.67 % (w/v) yeast nitrogen 
base without amino acids, 0.1 % (w/v) yeast 
extract (DIFCO) and amino acids (20 µg/ml) 
as needed. β-oxidation assays in intact cells 
were performed as described previously (9) 
with some modifications. Cells were grown 
overnight in media containing oleate to induce 
fatty acid β-oxidation. The β-oxidation 
capacity was measured in 50 mM MES, pH 
6.0, supplemented with 10 µM [1-14C]-fatty 
acids. Subsequently, [14C]-CO2 was trapped in 
2 M NaOH and used to quantify the rate of 
fatty acid oxidation. 
  
 
RESULTS 
 
CTS is targeted to the peroxisome in 
Saccharomyces cerevisiae- To determine the 
suitability of Saccharomyces cerevisiae 
(BSL1-11B) as a heterologous system for the 
biochemical characterisation of CTS, the CTS 
ORF was expressed from a low copy plasmid 
(pRS416-GPD) under the control of the strong, 
constitutive glyceraldehyde-3-phosphate 
dehydrogenase (GPD) promoter (34). To 
investigate whether CTS was appropriately 
targeted in the heterologous host, peroxisomes 
were purified on Iodixanol gradients from a 
“light mitochondrial fraction” of oleate-grown 
cells transformed with CTS/pRS416-GPD or 
the non-recombinant vector, as described (30). 
Total, cytosolic and the mitochondrial and 
peroxisomal fractions from the gradient  were 
analysed by SDS-PAGE, followed by 
immunoblotting with specific antibodies for 
the peroxisomal marker, thiolase (37) and the 
mitochondrial marker, adenine nucleotide 
carrier (AAC; ref. 38). Clean separation of 
mitochondria and peroxisomes was 
demonstrated by the absence of the 
peroxisomal marker from the mitochondrial 
fraction, and vice versa (Fig. 1, bottom two 
panels). When the fractions were probed with 
an affinity-purified antiserum raised to the C-
terminal NBD of CTS (16) a band of the 
expected size (ca. 130 kDa) was observed in 
the peroxisomal fraction isolated from cells 
transformed with CTS/pRS416-GPD (Fig. 1, 
middle panel). A doublet of cross-reacting 
bands (CTS*) of ca. 70 kDa was detected in 
the peroxisomal and mitochondrial fractions 
but was absent from the control (non-
recombinant vector) samples. Further 
experiments suggested that these bands arose 
from cleavage between the two halves of CTS 
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by an endogenous yeast protease (Fig. S1). 
Cleavage was not prevented in a Δpep4 
knockout strain of yeast (data not shown). To 
provide independent corroboration of 
peroxisomal localisation, CTS was tagged 
with CFP at the C-terminus and co-expressed 
in yeast with YFP-PTS1, a peroxisomal 
marker. Peroxisomes were observed as 
discrete spots in the YFP channel (Fig. 2B) 
and many of these coincided with the CFP 
signal (A), as indicated in the merge panel (C). 
Cells were also stained with Mitotracker to 
visualise mitochondria (E). The Mitotracker 
and CFP signals did not co-localise (F), 
suggesting that there was no significant 
amount of CTS present in the mitochondria 
and that the degradation products seen in 
immunoblots of the mitochondrial fraction 
could represent association with membranous 
fragments which co-fractionate with 
mitochondrial markers in the gradients.  
Membrane integration and topology of 
CTS- As a prerequisite to functional testing, 
the integration and topology of CTS in the 
yeast peroxisomal membrane were next 
evaluated. A “light mitochondrial fraction” 
(which contains mitochondria and 
peroxisomes, as well as some contaminating 
endoplasmic reticulum) was subjected to 
hypotonic lysis and centrifugation, to provide 
a membrane and soluble fraction. CTS, its 
associated degradation products and the 
integral membrane protein marker, AAC were 
detected exclusively in the membrane fraction, 
whereas the peripheral ER membrane protein, 
SRP72 (39), was partially soluble and partially 
membrane-associated (Fig. 3). Membranes 
were resuspended in either: sucrose buffer, 
alkaline sodium carbonate or high salt and re-
centrifuged. CTS, AAC and SRP72 all 
remained membrane-associated on 
resuspension and re-pelleting in sucrose 
buffer, but SRP72 was extracted by both high 
salt and sodium carbonate showing that, as 
expected, these treatments were effective at 
removing peripheral membrane proteins. Both 
CTS and AAC were present in the pellets from 
the carbonate and salt treatments, indicating 
that CTS behaves as an integral membrane 
protein. Notably, the cleavage products were 
also found in the pellets, indicating that they 
are also firmly integrated in the membrane. 
Partial proteolysis was used to 
investigate the topology of CTS within the 
peroxisomal membrane. A “light 
mitochondrial fraction” (100 g) was 
incubated with increasing amounts of trypsin, 
then separated into membrane-bound and 
soluble fractions and analysed by 
immunoblotting with the anti-CTS C-terminal 
antiserum, which recognises both NBDs (44). 
The membrane fractions (Fig. 4A) showed that 
full-length CTS was very sensitive to 
proteolysis and was almost completely 
degraded following incubation for 30 min at 0 
°C with 1% (w/w) trypsin. The endogenous 
cleavage products were also degraded at 
higher trypsin concentrations. Analysis of the 
soluble fractions (Fig. 4B) revealed the 
presence of a fragment of the expected size of 
the NBDs (ca. 25 kDa), which was produced 
by treatment with 0.5 % (w/w) trypsin but was 
completely degraded at concentrations greater 
than 10 % (w/w). Under these conditions, 
thiolase, which is a peroxisomal matrix 
protein, remained completely protected from 
digestion, unless Triton X-100 was added. 
This is consistent with the cleavage of the 
NBDs from the membrane at low 
concentrations of trypsin and their degradation 
at higher concentrations. Thus we conclude 
that the NBDs face the cytosol. The addition 
of 0.1 % (v/v) Triton X-100 did not result in a 
qualitative change in the cleavage pattern of 
the membrane associated species but rather 
accelerated the rate of cleavage, due to the 
solubilising effect of the detergent (not 
shown). 
CTS exhibits ATPase activity which is 
inhibited by AlFx- In order to assess the 
functionality of expressed CTS, the ATPase 
activity was measured in peroxisomes purified 
from CTS-expressing and control yeast. Initial 
experiments showed that activity was linear 
with respect to the amount of peroxisomal 
protein added, in the range of 0-20 µg, and 
linear with respect to time up to 60 min (Fig. 
S2A,B). In wild-type (BSL1-11B) and pxa1Δ 
backgrounds, control peroxisomes had a 
modest ATPase activity (black bars) that was 
not inhibited by ouabain, azide, concanmycin 
A or molybdate (data not shown), but which 
was strongly inhibited by AlFx (white bars; 
Fig. 5A.). The pxa1Δ knockout mutant had a 
similar level of activity to wild-type yeast, 
indicating that the background activity was not 
substantially contributed by Pxa1/Pxa2p. 
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Expression of CTS in both wild-type and 
pxa1Δ cells gave a 2.5-fold increase in 
activity, which was also sensitive to AlFx. The 
CTS-dependent ATPase activity was 
insensitive to sodium orthovanadate (not 
shown). Introduction of the NBD1 Walker A 
motif mutation, K487A, which abrogates 
function in planta (28), reduced ATPase 
activity to a level similar to that of the control. 
As a control, we determined that the mutant 
was correctly targeted to the peroxisome and 
expressed at a similar level to the wild-type 
protein (Fig. 5B).  
To investigate whether the ATPase 
activity ascribed to CTS demonstrated 
structure-linked latency, the ATPase assays 
were carried out both on intact and on 
osmotically-ruptured peroxisomes (Fig. S3). 
While peroxisomes from cells expressing CTS 
showed more than double the activity of the 
control, as seen in Fig. 5A, there was no 
difference in activity between ruptured and 
intact peroxisomes. The absence of latency is 
consistent with a cytosolic location of the 
NBDs as deduced from partial proteolysis 
experiments (Fig. 4). 
As an independent means of testing 
CTS functionality, its ability to bind to ATP 
agarose was also tested. Both full-length CTS 
and the cleavage products bound to ATP 
agarose (Fig. S4A) and were eluted with 10 or 
20 mM ATP (Fig. S4B), providing 
confirmation of proper folding and suggesting 
that the cleavage products most likely 
represent the two CTS halves which remain 
associated to form composite ATP binding 
sites, as would occur in the intact transporter 
(3,28). 
CTS complements the yeast pxa1 
pxa2Δ mutant- Since the biochemical data 
suggested that CTS was functional when 
expressed in yeast, we investigated the ability 
of CTS to complement an S. cerevisiae pxa1 
pxa2Δ mutant, for β-oxidation of different 
fatty acids. The CTS ORF was subcloned into 
pEL30, a yeast expression vector which 
contains the oleate-inducible catalase promoter 
and which was used successfully for 
expression of ALDP in S. cerevisiae (9). 
Peroxisomal targeting of CTS was confirmed 
by fractionation of organelles and 
immunoblotting (Fig. S5). Mutant cells 
transformed with CTS/pEL30 grew almost as 
well as the wild-type on oleate plates (Fig. 
6A), and somewhat better than cells 
transformed with the human peroxisomal ABC 
transporter, ALDP, in liquid medium (Fig. 
6B).  
CTS expressing pxa1 pxa2Δ  mutant 
yeast strains can oxidise a wide range of fatty 
acids The ability of pxa1 pxa2Δ- mutant cells 
expressing CTS to metabolise fatty acids of 
different chain length and saturation was 
tested and compared to that of cells expressing 
ALDP (Fig. 7). For each substrate, data were 
normalised to the rate of β-oxidation for wild-
type (WT= BJ1991) cells. WT rates of β-
oxidation for lauric (C12:0), palmitic (C16:0), 
stearic (C18:0), oleic (C18:1), linoleic 
(C18:2), behenic (C22:0) and docosahexanoic 
(C22:6) acids were 7.24 ±0.8, 1.06 ±0.1, 
0.95±0.2, 2.6±0.5, 2.73±0.51, 0.15±0.008, 
0.62±0.08 nmol/min/OD, respectively and the 
rate for lignoceric (C24:0) was 4.46±0.15 
pmol/h/OD. As shown previously, Pxa1/Pxa2p 
contribute to the β-oxidation of fatty acids of 
chain length C16 or greater, but not to the β-
oxidation of C12:0, as evidenced by the 
relative level of β-oxidation in the pxa1 pxa2Δ 
mutant transformed with vector lacking insert 
(6). For C16:0 and longer acyl chains, 
expression of CTS increased β-oxidation 
above the level seen for the non-recombinant 
control vector, restoring β-oxidation to 75-80 
% of the WT level. The Walker A motif 
mutant, CTSK487A did not restore β-oxidation, 
compared to the vector-transformed control. 
ALDP was only effective with longer chain 
substrates of length C22:0 and longer, in 
agreement with (9). The β-oxidation mutant, 
fox1, which lacks acyl CoA oxidase, did not 
metabolise any of the fatty acids tested (Fig. 
7). These data support the hypothesis that CTS 
has broad substrate specificity with regard to 
chain length and degree of desaturation. 
However, these in vivo measurements are 
constrained by the ability of yeast to 
metabolise different fatty acids and only 
provide indirect evidence for substrate 
specificity. Therefore we sought alternative, 
biochemical evidence for the ability of CTS to 
accept a range of substrates. 
Effects of potential substrates on the 
ATPase activity of CTS- The ATPase activity 
of many ABC transporters is increased above 
basal rates upon substrate binding (45-50). 
Exploiting this behaviour, it is possible to 
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screen a range of compounds to identify 
putative substrates for a given ATP 
transporter. Therefore we tested the effects of 
fatty acids and fatty acyl-CoAs on the ATPase 
activity of CTS when expressed from the 
vector pEL30 in the BJ1991 pxa1Δ strain. 
Substrates (10-1000 µM) were solubilised in 5 
% (w/v) hydroxyl propylated β-cyclodextrin 
(HPBCD). The effects of 10 µM substrates on 
activity are presented in Fig. 8A; black bars 
indicate activity with CTS; white bars are non-
recombinant vector controls. Control reactions 
in the presence of individual assay 
components [ATP (‘ATP only’), peroxisome 
extract (‘protein only’), FA-CoA (‘C-18-CoA 
only’) or FA(‘C18:1 only’)] showed only a 
very low rate of inorganic phosphate 
production (20 nmol Pi/min or less). In the 
CTS/pEL30-transformed cells, basal ATPase 
activity was 86.64 ± 2.49 nmol Pi/min/mg 
protein. This was increased in the presence of 
all fatty acyl CoAs tested, while the effects of 
fatty acids were marginal (Fig. 8A). CoASH 
had no effect on activity, but the non-
hydrolysable C14-etheno CoA increased CTS-
dependent basal ATPase activity, 
demonstrating that simulation of activity by 
FA-CoA was not due to release of FA by 
hydrolysis. Indole butyric acid and 2,4-
dichlorophenoxy butyric acid have both been 
proposed as substrates of CTS (17,18), but 
these compounds did not stimulate ATPase 
activity (data not shown). Unfortunately the 
corresponding CoA esters could not be tested 
as they are not commercially available.  No 
effect of any of the potential substrates was 
seen on the ATPase activity of non-
recombinant vector-transformed cells. To 
evaluate more precisely the effects of the 
different compounds, a stimulation index was 
calculated for each potential substrate, as 
defined in the Experimental Procedures 
section. From this, it is clear that FA-CoA give 
a higher stimulation of activity: ca. 2-fold, 
compared to 1.2-1.4-fold for FA (Fig. 8B). 
 
DISCUSSION 
 
Genetic and physiological evidence 
has indicated that CTS is involved in the 
transport of substrates into the peroxisome for 
β-oxidation but, to date, no direct biochemical 
data have been available to support this 
hypothesis. To address this, we have expressed 
CTS in S. cerevisiae, demonstrated that it is 
correctly targeted to peroxisomes in the 
heterologous host and is integrated into the 
peroxisomal membrane in a functional form, 
allowing complementation of a pxa1 pxa2Δ 
mutant.  
Through complementary cell 
fractionation and confocal microscopy 
approaches, it was shown that full length CTS 
is targeted to the peroxisome in yeast, which, 
taken together with other findings, suggests 
conservation of targeting of peroxisomal 
membrane proteins between plants, yeast, 
mammals and protozoa (51-54). Attempts to 
complement a pxa1 mutant with the 
CTS/pRS416-GPD construct gave inconsistent 
results (data not shown), suggesting that for 
complementation to work effectively either the 
expression of CTS has to be co-ordinated with 
the proliferation of peroxisomes (as would be 
expected to be the case when CTS expression 
is driven from the CAT promoter of pEL30) or 
that the presence of Pxa2p somehow interferes 
with the function of CTS. When ALDP 
(HsABCD1) was co-expressed with Pxa1p in 
yeast it was inactive but like CTS could 
complement a pxa1 pxa2 mutant (9). 
Carbonate and salt extraction 
demonstrated that this protein is integrated 
into the yeast peroxisomal membrane, 
consistent with its behaviour as an integral 
membrane protein in Arabidopsis (18), and 
partial proteolysis experiments indicated that 
the NBDs face the cytosol, as has been shown 
for the human peroxisomal ABC transporters, 
ALDP and PMP70 (55,56). This topology is 
consistent with the canonical model of ATP-
dependent transport of substrates from cytosol 
to the peroxisome lumen and rules out a model 
in which CTS utilises the peroxisomal pool of 
ATP supplied by the adenine nucleotide 
translocators, PNC1 and 2 (57,58). 
We were able to demonstrate ATPase 
activity in peroxisomes purified from cells 
expressing CTS, which was consistently two- 
to three-fold higher than that of peroxisomes 
isolated from control cells transformed with 
vector lacking insert. Interestingly, the level of 
control ATPase activity in the pxa1Δ knockout 
was not greatly different to that of wild-type 
cells, suggesting that the basal activity of 
endogenous Pxa1/Pxa2p is low, relative to 
other ATPases in the peroxisome fraction. 
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Independent confirmation of functionality was 
obtained by ATP-binding experiments in 
which full-length CTS bound to ATP-agarose 
and could be eluted with ATP. Expression of 
CTS bearing a K487A mutation in the Walker 
A motif, which abolishes function in planta, 
reduced peroxisomal ATPase activity to close 
to control levels, providing evidence of 
specificity. Both control and CTS-dependent 
ATPase activities were insensitive to vanadate 
(Vi), but were inhibited by AlFx. Vanadate and 
metal fluorides act as phosphate analogues, 
arresting ATP-utilising enzymes in the 
catalytic cycle by forming a stable 
Mg.ADP.inhibitor complex, but ABC 
transporters differ in their sensitivity to these 
inhibitors (46,47,59,60). In common with 
CTS, ALDP, PMP70 and TAP (transporter 
associated with antigen processing) are 
insensitive to vanadate, but susceptible to 
inhibition by metal fluorides (61-63).  
The ability of CTS to complement a 
pxa1 pxa2Δ mutant for growth on oleic acid 
and to support the β-oxidation of a range of 
fatty acids (C16:0-C24:0) provides further 
support for the ability of CTS to handle a 
broad range of substrates, in contrast to ALDP, 
which shows a marked preference for very-
long chain substrates (9). Evidence from yeast 
suggests that Pxa1/Pxa2p transports FA-CoAs 
and not FA (10), suggesting, by extension, that 
the same is also true for ALDP and CTS, since 
they complement the pxa1 pxa2Δ mutant (9, 
and this study) and the peroxisomal synthetase 
Faa2p is not required for metabolism of fatty 
acids with chain lengths longer than C14 (2). 
Both cytosolic and peroxisomal acyl CoA 
synthetases exist in Arabidopsis (29,64,65) but 
genetic data imply that CTS might transport 
free acids and not CoAs. Arabidopsis mutants 
and transgenics in which peroxisomal acyl 
CoA synthetases and peroxisomal adenine 
nucleotide translocators are down-regulated 
share the lipid mobilisation defect of cts 
mutants (29,57,58) and the peroxisomal acetyl 
CoA synthetase mutant, acn1 and the cts 
allele, acn2 are both impaired in acetate 
metabolism (19,66), suggesting that free acids 
must be activated in the peroxisome prior to β-
oxidation. Therefore the precise nature of the 
CTS substrates is of particular interest. As a 
number of ABC transporters exhibit substrate-
stimulated ATPase activity (46-49,67), we 
tested both FA and FA-CoA for effects on 
basal ATPase activity. Comparison of the 
stimulation indices for free acids and acyl-
CoA esters indicated that CoAs gave a 
markedly greater stimulation than the 
corresponding free FA. The non-hydrolysable 
etheno-CoA species also stimulated basal 
ATPase, providing evidence that the CoA 
ester, rather than the free FA hydrolysis 
product is responsible for this effect.  
Stimulation of CTS-dependent 
ATPase activity was observed in the 
concentration range of 10-100 µM FA-CoA. It 
is noteworthy that higher concentrations (1000 
µM) of FA and FA-CoA had an inhibitory 
effect on the basal ATPase activity of CTS 
(not shown), possibly due to a detergent effect. 
However, the observation that 100 μM of 
various non-ionic and anionic detergents did 
not affect the basal ATPase activity of CTS 
(data not shown) suggests that the effects 
observed at 100 µM reflect a specific 
interaction of the substrates with CTS. The 
critical micelle concentrations (CMCs) of 
medium to long-chain acyl CoAs are reported 
to be in the range of 5-200 µM depending on 
chain length, degree of saturation and the ionic 
strength of the buffer (68). Below the CMC, 
acyl-CoAs exist in molecular solution, but 
above the CMC, the concentration of free 
acyl-CoA is independent of the total 
concentration. In mammalian cells, the total 
cellular acyl-CoA concentration was reported 
to be in the range of 5-160 µM, depending on 
the metabolic state of the cell, although the 
majority of the acyl-CoA pool is likely to be 
protein-bound (68,69). Acyl-CoA 
concentrations in plants are lower: in the range 
of 3 to 6 µM in developing Brassica napus 
embryos and in Arabidopsis seedlings (70). 
The potential disparity between the 
stimulatory concentration determined in this 
study and the reported concentration of acyl-
CoAs in plant cells possibly reflects the 
differences between in vivo and in vitro 
conditions. For FA and FA-CoA to interact 
with CTS, it is probable that they partition into 
the peroxisomal membrane, where they reach 
a much higher local concentration (71-74). 
Nevertheless, our data are consistent with 
those of Guimarães et al. (14), in which FA-
CoA (but not FA) provoked substrate-induced 
conformational changes in ALDP when 
supplied at 200 µM. 
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Although the stimulation of basal 
ATPase activity by FA-CoA species is 
consistent with CoA esters, rather than free 
FA, being bona fide CTS substrates, other 
interpretations are possible: not all ABC 
transport substrates stimulate ATP hydrolysis 
and conversely, not all compounds that 
stimulate ATPase activity are substrates 
(46,47,49,75-77) therefore FA as potential 
substrates cannot be excluded. Nevertheless, 
collectively, our data support the notion that 
CTS is a transporter of acyl-CoAs. It has been 
proposed that CTS might cleave the CoA 
moiety during transport, thus requiring its re-
esterification inside the peroxisome (29); 
alternatively, cleavage may be carried out by 
peroxisomal thioesterases (78), which would 
agree with both the biochemical and genetic 
data. Ultimately, transport assays using 
purified, reconstituted CTS protein will be 
essential to determine unequivocally the 
biochemical function of this intriguing 
membrane protein. However, this study has 
advanced our understanding of the function of 
CTS by identifying potential substrates and by 
developing a yeast expression system which 
may prove useful for the expression, 
purification and reconstitution of CTS to 
enable testing of these substrates via transport 
assays. 
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Fig. 1. CTS targets to peroxisomes in yeast. A “light mitochondrial fraction” was prepared from 
oleate-grown BSL1-11B cells transformed with a CTS expression plasmid (CTS/pRS416-GPD) or 
with non-recombinant vector (control) and separated on an Iodixanol density gradient. Mitochondrial 
and peroxisomal fractions from the gradient along with total and cytosolic samples were separated by 
SDS-PAGE (30 μg protein per lane), stained with Coomassie Blue (upper panel) or immunoblotted 
with antibodies specific for CTS, thiolase (peroxisomal marker), and mitochondrial adenine 
nucleotide translocator (AAC; mitochondrial marker).The mobilities of marker proteins of known 
mass (kDa) are indicated on the left hand side of the figure. 
Fig. 2. CTS-CFP targets to peroxisomes in yeast. Yeast strain BLS1-11B cells co-transformed with 
the CTS-CFP and YFP-PTS1 expression plasmids were grown on WOYD and transferred to oleate 
medium. Mitochondria were labelled with 12.5 nM Mitotracker® and visualised by confocal 
microscopy, as described in Experimental Procedures. (A) CTS-CFP, (B) YFP-PTS1, (C) Merge of A 
and B, (D) differential interference contrast (DIC) image, (E) Mitotracker®, (F) Mitotracker®, and 
CTS-CFP. E and F are the same group of cells as A and B but a different optical section. Examples of 
co-localisations are indicated by arrowheads. Scale bar = 5 μm. 
 
Fig. 3. CTS is an integral membrane protein in S. cerevisiae. Organelles (“light mitochondrial 
fraction”) were lysed in a hypotonic buffer in the presence of protease inhibitors and membranes were 
separated from soluble proteins by centrifugation at 100,000 g. Membranes were then extracted with 
alkaline sodium carbonate buffer, pH 11.5 (“carb”), 1 M NaCl (“salt”) or sucrose buffer (“suc”), 
followed by centrifugation at 100,000 g to pellet membranes. Lysate fractions (total, T; membrane, 
M; soluble, S) plus pellet (P) and supernatant fractions (S) were separated by SDS-PAGE (30 μg per 
lane) followed by immunoblotting with antibodies raised against CTS, AAC (integral membrane 
protein marker) and SRP72 (peripheral membrane protein marker).  
 
Fig. 4. Determination of orientation of NBDs by controlled proteolysis. Aliquots (100 µg protein) of a 
“light mitochondrial fraction” were digested with the quantities of trypsin indicated for 30 min at 0º 
C, in the presence or absence of detergent (Triton X-100). The reactions were stopped by the addition 
of soybean trypsin inhibitor (SBTI) and subjected to carbonate extraction followed by centrifugation 
at 100 000 g to pellet the membranes. Pellet and supernatant fractions were separated by SDS-PAGE, 
transferred to nitrocellulose and probed with CTS- or thiolase-specific antibodies. ”Mock” indicates a 
reaction in which SBTI was added before trypsin. (A) Membrane fraction following tryptic digestion 
in the absence of detergent. (B) Supernatant fraction following tryptic digestion in the absence (upper 
two panels) and presence (lower panel) of Triton X-100.  
 
Fig. 5. Basal ATPase activity of wild type CTS and K478A mutant. Peroxisomes were isolated from 
oleate-grown wild-type BSL1-11B or pxa1Δ mutant yeast (PXA1KO), transformed with vectors 
encoding CTS, CTSK487A or lacking an insert (control). (A) ATPase activity was measured in the 
absence (black bars) or presence (open bars) of 10 mM AlFx. All samples were analysed in triplicate, 
and the experiment was repeated three times. The data were used to compute the means and the 
standard error of the mean (SEM). The plot shows mean ± 95% Confidence limit (CL) (computed 
from SEM for n=9) as indicated by the error bars. Data were analysed by 2-way ANOVA, which 
indicated significantly higher ATPase activity of wild-type CTS compared to the K487A mutant 
(P<0.05). The difference in the ATPase activity between the control BSL1-11B and the control pxa1Δ 
mutant was insignificant. (B) Total, cytosol, peroxisome and mitochondria fractions were isolated 
from oleate-grown BSL1-11B cells (upper panel) or pxa1Δ cells (lower panel), transformed with the 
indicated constructs. Proteins (30 μg per lane) were separated by SDS-PAGE and immunoblotted with 
a CTS-specific antibody.  
 
Fig. 6. CTS complements the S. cerevisiae  pxa1 pxaΔ2 mutant for growth on oleate. Growth of wild-
type and mutant cells on solid (A) and liquid (B) oleate medium. Strains shown are as follows: wild-
type (WT; BJ1991), fox1Δ (acyl-CoA oxidase deletion mutant; negative control), pxa1 pxa2Δ mutant 
cells transformed with CTS/pEL30, ALDP/pEL30 or vector lacking insert (two independent 
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transformants of CTS/pEL30 are shown in B).  Data are representative of at least two independent 
experiments.  
 
Fig. 7. β-oxidation of different fatty acids in wild-type and transformed pxa1 pxa2Δ mutant cells. 
Cells grown on oleate medium were incubated with [1-14C] fatty acids, followed by β-oxidation 
activity measurements. Results are presented as % relative to the rate of oxidation by wild-type cells 
for each fatty acid. Bars represent means ± SE of the mean (n=3). 
 
Fig. 8. Effects of fatty acids and fatty acyl-CoAs on the ATPase activity of CTS. ATPase activity was 
measured in the presence of 10 μM or 100 μM fatty acids or fatty acyl-CoAs using  peroxisomes (10 
μg protein) isolated from pxa1Δ cells transformed with CTS/pEL30 (black bars) or vector lacking 
insert (open bars). (A) ATPase activities measured in the presence or absence of 10 μM fatty 
acids/fatty acyl CoAs; bars represent means ± SE of the mean (n=3). (B) The ATPase activities 
obtained in (A), or in a similar experiment performed using 100 μM fatty acids/fatty acyl CoAs, were 
used to calculate the CTS ATPase activity relative to that seen in the basal state in the absence of 
substrate (“stimulation index”), according to the formula: [CTS expressing (stimulated) - control 
(stimulated)] / [CTS (unstimulated) - control (unstimulated)]. The basal ATPase activity is defined as 
having a stimulation index of 1 (represented by a broken line across the graph) and values above 1 
indicate the degree of stimulation relative to the basal ATPase activity of CTS. Black bars: 100 µM 
substrate; open bars, 10 µM substrate. 
 
 
TABLES 
Table 1. Yeast strains used in this study 
 
Strain Genotype Source 
BSL1- 11B   (WT)    MATa, lys2Δ0, his4Δ519, Ura3Δ0, leu2Δ2                            79 
BSL1-11B (pxa1Δ)   MATa, lys2Δ0, his4Δ519, Ura3Δ0, leu2Δ2,  
YPL147w::kanMX4                                                          
This study  
BJ1991 (WT) MATα, leu2, trp1, ura3-251, prb1-1122, pep4-3 
 
9 
BJ1991 (pxa1Δ) MATα, leu2, trp1, ura3-251, prb1-1122, pep4-3 
YPL147w::LEU2   
9 
BJ1991(pxa1 
pxa2Δ) 
MATα, leu2, trp1, ura3-251, prb1-1122, pep4-3 
YKL188c::kanMX4;  YPL147w::LEU2 
9 
BJ1991 (fox1Δ) MATα, leu2, trp1, ura3-251, prb1-1122, pep4-3 
(YGL205W::kanMX4) 
9 
 
 
 
 
 
